Regulatory Landscape for Raw Materials: CMC Considerations
ISPE
AUGUST 30, 2022
During the pandemic, the pharmaceutical industry faced challenges in the production of COVID-19 therapeutics and vaccines to meet global demand, as well as mitigation of drug shortages for non-COVID-19-related products, without compromising product quality or patient safety. Journal of Pharmaceutical Sciences 111, no. 5 (May 2022): 1232–1244.
52 
Let's personalize your content